Breast tumor recurrence was never again detected, and subsequent 2nd tumor injections did not induce cancers in Treg-cell-specific SRC-3 KO mice and in mice receiving ACT with SRC-3 KO Tregs after eradication of the first tumor. This evidence concerns the gene NCOA3 and neoplasm.